The role of circular RNA in Diabetic Nephropathy
- PMID: 35693742
- PMCID: PMC9149631
- DOI: 10.7150/ijms.71648
The role of circular RNA in Diabetic Nephropathy
Abstract
Diabetic nephropathy (DKD) is the most common chronic microvascular complication of diabetes. About 20%-40% of diabetics develop DKD, which eventually leads to chronic kidney failure. Although progress has been made in diagnosis and treatment tools, diabetic nephropathy is still a major clinical problem. In recent years, circular RNA (CircRNA) has become a research hotspot. CircRNA is a non-coding RNA formed by covalently closing the 5 'and 3' ends of the precursor RNA. CircRNA has powerful biological functions. CircRNA can regulate the expression of target genes through competitive binding with microRNA, thus playing the biological role of endogenous RNA (CeRNA). Many studies have shown that circRNAs plays an important role in malignant tumors, autoimmune system diseases, coronary heart disease and other diseases. More and more studies have shown that it can also be used as a biomarker of diabetes and diabetic nephropathy. This review summarizes the origin, classification, biogenesis and regulatory mechanisms of circRNAs. In addition, the pathogenesis and clinical significance of circRNAs as competing endogenous RNAs involved in diabetic nephropathy were also introduced. This will help us fully understand the pathological mechanism of diabetic nephropathy and develop new therapeutic targets or treatment options to improve the prognosis of patients with diabetic nephropathy.
Keywords: biomarker; circular RNAs; diabetic nephropathy; mesangial cells; tubule cells.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures



Similar articles
-
Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.Pathol Res Pract. 2021 Nov;227:153618. doi: 10.1016/j.prp.2021.153618. Epub 2021 Sep 15. Pathol Res Pract. 2021. PMID: 34649056 Review.
-
Perspectives of circular RNAs in diabetic complications from biological markers to potential therapeutic targets (Review).Mol Med Rep. 2023 Oct;28(4):194. doi: 10.3892/mmr.2023.13081. Epub 2023 Sep 8. Mol Med Rep. 2023. PMID: 37681455 Free PMC article.
-
Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.J Cell Physiol. 2019 Feb;234(2):1469-1476. doi: 10.1002/jcp.26959. Epub 2018 Jul 27. J Cell Physiol. 2019. PMID: 30054916
-
Non-Coding RNA and Diabetic Kidney Disease.DNA Cell Biol. 2021 Apr;40(4):553-567. doi: 10.1089/dna.2020.5973. Epub 2021 Mar 17. DNA Cell Biol. 2021. PMID: 33733861 Review.
-
Circular RNAs: An emerging precise weapon for diabetic nephropathy diagnosis and therapy.Biomed Pharmacother. 2023 Dec;168:115818. doi: 10.1016/j.biopha.2023.115818. Epub 2023 Nov 6. Biomed Pharmacother. 2023. PMID: 37939612 Review.
Cited by
-
Hsa_circ_0008360 promotes high glucose-induced damage in HK-2 cells via miR-346/WNT2B axis.J Endocrinol Invest. 2024 Sep;47(9):2325-2337. doi: 10.1007/s40618-024-02326-1. Epub 2024 Mar 12. J Endocrinol Invest. 2024. PMID: 38472721
-
CircRNAs: versatile players and new targets in organ fibrosis.Cell Commun Signal. 2023 May 2;21(1):90. doi: 10.1186/s12964-023-01051-1. Cell Commun Signal. 2023. PMID: 37131173 Free PMC article. Review.
-
Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.J Clin Med. 2023 Feb 11;12(4):1447. doi: 10.3390/jcm12041447. J Clin Med. 2023. PMID: 36835983 Free PMC article.
-
Sirtuin 2 exacerbates renal tubule injury and inflammation in diabetic mice via deacetylation of c-Jun/c-Fos.Cell Mol Life Sci. 2025 Jan 21;82(1):45. doi: 10.1007/s00018-024-05567-8. Cell Mol Life Sci. 2025. PMID: 39833479 Free PMC article.
-
CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease.Front Immunol. 2023 Sep 6;14:1226962. doi: 10.3389/fimmu.2023.1226962. eCollection 2023. Front Immunol. 2023. PMID: 37744330 Free PMC article.
References
-
- Molinaro R, Dauscher C. Complications resulting from uncontrolled diabetes. MLO Med Lab Obs. 2017;49:20. 22. - PubMed
-
- Li X, Yang L, Chen LL. The Biogenesis, Functions, and Challenges of Circular RNAs. Mol Cell. 2018;71:428–442. - PubMed
-
- Chen RX, Liu HL, Yang LL. et al. Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci. 2019;23:8771–8778. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical